Fig. S1. Comparison of human ApoCIII between human and transgenic pigs by western blot.

Fig. S2. SDS/PAGE of the VLDLs separated from transgenic and wild-type pig plasma, adjusted for the same amount triglyceride.

Fig. S3. Dilution effect on LPL activity of post-heparin plasma from wild-type and transgenic pigs.

Fig. S4. Western blot of ApoCIII of plasma for the other four piglets at age 5 months.

Fig. S5. RT-PCR of different tissues from transgenic and nontransgenic piglets with GAPDH as loading control.

Please note: As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer-reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.

FEBS_8401_sm_FiguresS1-S5.zip244KSupporting info item

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.